Medigene AG maintains revenue guidance for the fiscal year 2022. For the period, the company continues to expect revenues of EUR 23 million to EUR 28 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.178 EUR | +1.99% |
|
-0.86% | -24.59% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.59% | 36.79M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.79% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Maintains Revenue Guidance for the Fiscal Year 2022